靶点- |
作用机制- |
|
|
|
非在研适应症- |
最高研发阶段临床前 |
首次获批国家/地区- |
首次获批日期- |
靶点- |
作用机制- |
|
|
|
非在研适应症- |
最高研发阶段临床前 |
首次获批国家/地区- |
首次获批日期- |
A prospective, multicenter, single-blind, randomized, active-controlled, non-inferiority pivotal study to evaluate the safety and efficacy of Stopad versus Tachosil in patients with oozing after primary control of bleeding by standard techniques (such as sutures, ligatures, clips, vascular stapler, electrocautery, local radiofrequency ablation) in open hepatic resection
A Dose Block-Randomized, Double-Blinded, Placebo-Controlled, Single-Dosing, Dose Escalation Phase I Clinical Trial to Evaluate Tolerability, Safety and Pharmacodynamics of BB-rB1 (recombinant batroxobin) in Healthy Volunteers
100 项与 Biobud Ltd. 相关的临床结果
0 项与 Biobud Ltd. 相关的专利(医药)
100 项与 Biobud Ltd. 相关的药物交易
100 项与 Biobud Ltd. 相关的转化医学